Analyst, Insights at Guidepoint

Shanghai, Shanghai, China -

Full Time

Start Date

Immediate

Expiry Date

29 Dec, 25

Salary

0.0

Posted On

30 Sep, 25

Experience

5 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

Research Coverage, Industry Analysis, Report Creation, Content Development, Content Editing, Reporting, Strategic Collaboration, Compliance & Integrity, Interpersonal Skills, Organizational Skills, Time Management, Analytical Skills, Fluency in English, Fluency in Mandarin, Intellectual Curiosity, Passion for Learning

Industry

Information Services

Description

Overview: Guidepoint Insight is seeking an Equity Analyst to support the expansion of our research coverage of China biotech, medtech and healthcare services companies. This role plays a critical part in building and scaling the Guidepoint Library, a central resource offering transcript-based insights through teleconferences with KOLs, and industry experts. These insights, conceptualized and hosted by former investment professionals, industry veterans and former scientists, help Guidepoint's institutional clients make well-informed decisions across sectors like healthcare, industrials, technology, consumer, and more. As an Equity Analyst, working in Shanghai you will be responsible for developing deep research coverage, facilitating expert-led discussions, and ensuring high-quality content creation. Reporting directly to the Director of Research, you will be instrumental in creating content that spans topics such as scientific basis of the platforms, competitiveness of existing and upcoming products of both public listed and private healthcare companies, industry landscape, regulatory decisions, product launches and go-to-market strategies. You will also lead efforts to recruit and vet experts, ensuring that the insights gathered are accurate, relevant, and valuable to our clients. What You'll Do: Research Coverage: Monitor a coverage universe of Chinese public and private companies in biotech, pharma, medtech and services. Industry Analysis: Track key market and business drivers, including material news flows, earnings releases, investor presentations, clinical trials, medical conferences, product launches within your coverage companies and therapeutic indications. Report Creation: Collect and organize clinical trial information and results, analyze the mechanisms of action (MOA) of drug candidates, investigate clinical paradigms for disease treatment in China, and prepare reports. Content Development: Create and moderate teleconferences featuring experts from Guidepoint’s network summarized in high-quality, detailed transcripts. Content Editing: Ensure high-quality content creation and editing of teleconference transcripts. Summarize, edit, and vet key discussion points of these teleconferences. Reporting: Collaborate with the Director of Research xxx to drive the growth of Guidepoint’s content library, scaling research coverage across multiple industries. Strategic Collaboration: Work closely with cross-functional teams, to align research initiatives with business objectives and market demands. Compliance & Integrity: Uphold Guidepoint’s compliance policies by ensuring that expert profiles and teleconference content adhere to company protocols. What You Have: Master or Advanced degrees in medicine, biological sciences or equivalent academic qualifications in medical professional degrees. Candidates with Ph.D. degree are preferred. 3+ years of experience in financial services, investment research, covering Biotech / Pharma sector. 3+ years of experience in pharmaceutical/biotech companies on competitive assessment, drug development, or business development will be considered as well. Demonstrated ability to understand and analyze pathophysiology of the disease, biological rationale of therapeutic targets, clinical data, drug labels and competitive dynamics. Strong understanding of institutional buy-side/sell-side research and investing workflows. Ability to work effectively in a fast-paced, entrepreneurial environment with a strong sense of ownership. Excellent organizational and time-management skills. Strong interpersonal skills with the ability to communicate effectively with professionals at all levels. Intellectual curiosity and a passion for learning about new industries and trends. Fluent in English and Mandarin, both written and verbal. What We Offer: Competitive compensation Entrepreneurial environment, autonomy, and fast decisions International exposure to the global Guidepoint service teams Casual work environment Summer and winter team events If you are passionate about research and possess a proven ability to drive innovation, we invite you to apply for this exciting opportunity at Guidepoint Insight. Please submit your resume detailing your relevant experience and accomplishments. About Guidepoint: Guidepoint is a leading research enablement platform designed to advance understanding and empower our clients’ decision-making process. Powered by innovative technology, real-time data, and hard-to-source expertise, we help our clients to turn answers into action. Backed by a network of nearly 1.75 million experts and Guidepoint’s 1,600 employees worldwide, we inform leading organizations’ research by delivering on-demand intelligence and research on request. With Guidepoint, companies and investors can better navigate the abundance of information available today, making it both more useful and more powerful. At Guidepoint, our success relies on the diversity of our employees, advisors, and client base, which allows us to create connections that offer a wealth of perspectives. We are committed to upholding policies that contribute to an equitable and welcoming environment for our community, regardless of background, identity, or experience. #LI-Recruiter# #LI-ONSITE

Responsibilities

The Equity Analyst will develop deep research coverage and facilitate expert-led discussions to ensure high-quality content creation. This role involves monitoring a coverage universe of Chinese public and private companies in biotech, pharma, medtech, and services.